Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Kaplan Fox Encourages Tenax Therapeutics, Inc. (NASDAQ: TENX) Investors to Contact the Firm Before the Deadline on December 28, 2026

accessnewswire.com
TENX

Lincoln Educational Services Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LINC

prnewswire.com
LINC

Data Center Cooling CDU Pumps Market to Reach USD 5,500.47 Million by 2035 as AI Racks Move to Liquid Cooling and Megawatt-Scale CDUs

globenewswire.com
VRT ETN FLS

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

globenewswire.com
CRMD HRTX

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference

globenewswire.com
AUTL

Silexion Therapeutics Announces 1-for-24 Reverse Share Split

globenewswire.com
SLXN

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Lincoln Educational Services (LINC), FuelCell Energy, Inc. (FCEL), and AST SpaceMobile, Inc. (ASTS) Announced by Holzer & Holzer, LLC

globenewswire.com
LINC FCEL ASTS

Octave introduces Attune Facilities, bringing AI-powered facilities management and spatial intelligence to complex multi-site operations

globenewswire.com
OCTV

Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

globenewswire.com
GILD

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026

globenewswire.com
GMED
View all news →